PsychoGenics, Dainippon Sumitomo deal

PsychoGenics received a milestone payment from Dainippon's Sunovion Pharmaceuticals Inc. subsidiary under an August 2007 deal to develop treatments for CNS disorders. The milestone was triggered by FD...